Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4193-4198

  Chiappetta, G ^a   Tallini, G ^d   De Biasio, M C ^a   Manfioletti, G ^b   Martinez Tello, F J ^e   Pentimalli, F ^a   De Nigris, F ^a   Mastro, A ^a   Botti, G ^a   Fedele, M ^a   Berger, N ^f   Santoro, M ^a   Giancotti, V ^b   Fusco, Alfredo ^c,g  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f Hopital de l'Antiquaille   (France)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP PROTEIN;

ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; THYROID NODULE;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADULT; BIOPSY, NEEDLE; CARCINOMA; CARCINOMA, PAPILLARY; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 0032530892     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Vander, J. B., Gaston, E. A., and Dawber, T. R. The significance of nontoxic nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern. Med., 69: 537-540, 1968.
2. Mazzaferri, E. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am. J. Med., 93: 359-362, 1992.
3. Burch, H. B. Evaluation and management of the solid thyroid nodule. Endocrinol. Metab. Clin. North Am., 24: 663-710, 1995.
4. Hedinger, C, Williams, E. D., and Sobin, L. H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer (Phila.), 63: 908-911, 1989.
5. Williams, E. D. The aetiology of thyroid tumors. J. Clin. Endocrinol. Metab., 8: 193-207, 1979.
6. Rosai, J., Carcangiu, M. L., and DeLellis, R. A. Tumors of the thyroid gland. In: Atlas of Tumor Pathology, Series 3, Fascicle 5. Washington DC: Armed Forces Institute of Pathology, 1992.
7. Chiappetta, G., Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V., and Fusco, A. The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene, 10: 1307-1314, 1995.
8. Grosschedl, R., Giese, K., and Pagel, J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet., 10: 94-100, 1994.
9. Lovell-Badge, R. Developmental genetics. Living with bad architecture. Nature (Lond.), 376: 725-726, 1995.
10. Johnson, K. R., Lehn, D. A., Elton, T. S., Barr, P. J., and Reeves, R., Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMGI(Y). J. Biol. Chem., 263: 18338-18342, 1988.
11. Manfioletti, G., Giancotti, V., Bandiera, A., Buratti, E., Sautiewre, P., Cary, P., Crane-Robinson, C., Coles, B., and Goodwin, G. H. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res., 19: 6793-6797, 1991.
12. Chiappetta, G., Avantaggiato, V., Visconti, R., Fedele, M., Battista, S., Trapasso F., Merciai, B. M., Fidanza, V., Giancotti, V., Santoro, M., Simeone, A., and Fusco, A. High level expression of the HMGI(Y) gene during embryonic development. Oncogene, 13: 2439-2446, 1996.
13. Giancotti, V., Berlingieri, M. T., Di Fiore, P. P., Fusco, A., Vecchio, G., and Crane-Robinson, C. Changes in nuclear proteins following transformation of rat thyroid epithelial cells by a murine sarcoma retrovirus. Cancer Res., 45: 6051-6057, 1985.
14. Giancotti, V., Pani, B., D'Andrea, P., Berlingieri, M. T., Di Fiore, P. P., Fusco, A., Vecchio, G., Philip, R., Crane-Robinson, C., Nicolas, R. H., Wright, C. A., and Goodwin, G. H. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with ras and v-mos oncogenes and by co-transfeclion with c-myc and Polyoma Middle T genes. EMBO J., 6: 1981-1987, 1987.
15. Giancotti, V., Buratti, E., Perissin, L., Zorzet, S., Baimain, A., Portella, G., Fusco, A., and Goodwin, G. H. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res., 184: 538-545, 1987.
16. Ram, T. G., Reeves, R., and Hosick, H. L. Elevated high mobility group I (Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res., 53: 2655-2660, 1993.
17. Bussemakers, M. G., Van de Ven, W. J. M., Debruyne, F. M. J., and Schalken, J. Identification of high mobility group protein I (Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51: 606-611, 1991.
18. Tmimi, Y., van der Poel, H. G., Denyn. M. M., Umbas, R., Karthaus, H. F. M., Debruyne, F. M., and Shalken, J. A. Increased expression of high mobility group protein I (Y) in high-grade prostate cancer determined by in situ hybridization. Cancer Res., 53: 5512-5516, 1993.
19. Fedele, M., Bandiera, A., Chiappetta, G., Battista, S., Viglietto, G., Manfioletti, G., Casamassimi, A., Santoro, M., Giancotti, V., and Fusco, A. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res., 56: 1896-1901, 1996.
20. Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V., and Fusco, A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol., 15: 1545-1553, 1995.
21. Jackson, D. P., Quirke, P., Lewis, F., Boylston, A. W., Sloan, J. M., Robertson, D., and Taylor, G. R. Detection of measles virus RNA in paraffin-embedded tissue. Lancet, 1: 1391, 1989.
22. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
23. Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A., Melillo, R. M., Bongarzone, I., Pierotti, M. A., Della Porta, G., Berger, N., Peix, J. L., Paulin, C., Fabien, N., Grieco, M., V. Ecchio, G., Jenkins, R. B., and Fusco, A. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype. J. Clin. Invest., 89: 1517-1522, 1992.
24. Tallini, G., Dal Cin, P., Rhoden, K. J., Chiappetta, G., Manfioletti, G., Giancotti, V., Fusco, A., Van den Berghe, H., and Sciot, R. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am. J. Pathol., 151: 37-43, 1997.
25. Tkachenko, A., Ashar, H. R., Meloni, A. M., Sandberg, A. A., and Chada, K. K. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res., 57: 2276-2280, 1997.
26. Williams, A. J., Powell, W. L., Collins, T., and Morton, C. C. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am. J. Pathol., 150: 911-918, 1997.
27. Xiao, S., Lux, M. L., Reeves, R., Hudson, T. J., and Fletcher, J. A. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am. J. Pathol., 150: 901-910, 1997.
28. Battista et al., Oncogene, 1998, in press.
29. Califano, D., Monaco, C., Santelli, G., Giuliano, A., Veronese, M. L., Berlingieri, M. T., de Franciscis, V., Berger, N., Trapasso, F., Santoro, M., Viglietto, G., and Fusco, A. Thymosin β-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res., 58: 823-828, 1998.
30. Takano, T., Matsuzuka, F., Sumizaki, H., Kuma, K., and Amino, N. Rapid detection of specific mRNAs in thyroid carcinomas by reverse transcription-polymerase chain reaction with degenerate primers: specific expression of oncofetal fibronectin mRNA in papillary carcinoma. Cancer Res., 57: 3792-3797, 1997.